Company Badge
USPTO Data Jan 1 1976 - Dec 30 2025
74 Patents
#8 in Oslo
#19 in Norway
#9,724 in the World
Optinose As
Forward Citations = 3,333
32 inventors:
Optinose As
CIPO Patents = 9
EPO Patents = 26
Trademarks = 7
Forward Citations = 3,333
Loading Chart...
Loading Chart...
32 inventors (with patents filed for the assignee):
Per Gisle Djupesland (71 out of 79 patents)
Colin David Sheldrake (14 out of 19 patents)
Roderick Peter Hafner (12 out of 29 patents)
4. Ramy A Mahmoud (7 out of 10 patents)
5. Michael Leclerc (6 out of 7 patents)
6. Joseph M Gordon (6 out of 65 patents)
7. Shane Siwinski (5 out of 17 patents)
8. Justin Fisk (4 out of 46 patents)
9. Rune Harald Gaarder (3 out of 3 patents)
10. Stuart Brian William Kay (3 out of 20 patents)
11. Kate Dudgeon (3 out of 3 patents)
12. Martin Joseph Murphy (3 out of 3 patents)
13. Andrew Gordon Pocock (3 out of 19 patents)
14. Mark Joseph Guarraia (3 out of 75 patents)
15. Simon James Smith (2 out of 24 patents)
Core Competencies:
Nasal Delivery
Intranasal Administration
Delivery Devices
Oxytocin Delivery
Nasal Administration
Nosepiece Unit
Powder Delivery Devices
Nasal Devices
74 patents:
OptiNose AS is a pharmaceutical company that specializes in innovative nasal drug delivery solutions. We develop and commercialize products that optimize the treatment of medical conditions through the nose. Our patented technology, called Exhalation Delivery System (EDS), enables targeted drug delivery deep into the nasal cavity, providing improved efficacy and patient convenience. At OptiNose, we aim to improve the lives of patients by advancing the science of nasal drug delivery and providing innovative treatment options.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
9 patents (CIPO):
Please report any incorrect information to support@idiyas.com
26 patents (EPO):
Please report any incorrect information to support@idiyas.com